Vitamin D Status and Chronic Obstructive Pulmonary Disease: A Prospective General Population Study

Objectives Vitamin D deficiency is common among persons with chronic obstructive pulmonary disease (COPD). Whether vitamin D affects the development and deterioration of COPD or is a consequence of the disease lacks clarity. We investigated the association between vitamin D status and prevalent and incident COPD in the general population. Methods We included a total of 12,041 individuals from three general population studies conducted in 1993–94, 1999–2001, and 2006–2008, respectively, with vitamin D measurements. Information on COPD was obtained from the Danish National Patient Register and The Danish Registry of Causes of Death. Results There were 85 prevalent and 463 incident cases of COPD (median follow-up 9.7 years). We found a statistically significant inverse association between vitamin D status and prevalent COPD with odds ratio = 0.89 (95% confidence interval, CI: 0.79, 1.0), but no statistically significant association with incident COPD with a hazard ratio = 0.98 (95% CI: 0.94, 1.0), respectively, per 10 nmol/l higher vitamin D status, when adjusted for possible confounders. Conclusions We found a statistically significant inverse cross-sectional association between vitamin D status and COPD, but no association between vitamin D status and incident COPD.

[1]  T. Jørgensen,et al.  Socioeconomic position and participation in baseline and follow-up visits: the Inter99 study , 2014, European journal of preventive cardiology.

[2]  C. Pedersen,et al.  Serum Vitamin D in Patients with Chronic Obstructive Lung Disease Does Not Correlate with Mortality – Results from a 10-Year Prospective Cohort Study , 2013, PloS one.

[3]  E. Wouters,et al.  Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease , 2013, Annals of medicine.

[4]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[5]  T. Jørgensen,et al.  Vitamin D Status and Cause-Specific Mortality: A General Population Study , 2012, PloS one.

[6]  K. Bønnelykke,et al.  Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations. , 2012, The Journal of allergy and clinical immunology.

[7]  P. Pfeffer,et al.  Vitamin D and lung disease , 2012, Thorax.

[8]  P. Bakke,et al.  Chronic Obstructive Pulmonary Disease Is Associated with Low Levels of Vitamin D , 2012, PloS one.

[9]  W. Grant,et al.  Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate , 2012, Dermato-endocrinology.

[10]  A. Linneberg,et al.  Determinants of vitamin D status in a general population of Danish adults. , 2012, Bone.

[11]  K. Bønnelykke,et al.  Interaction between filaggrin null mutations and tobacco smoking in relation to asthma. , 2012, The Journal of allergy and clinical immunology.

[12]  D. Niewoehner,et al.  Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. , 2012, American journal of respiratory and critical care medicine.

[13]  M. Decramer,et al.  High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease: A Randomized Trial , 2012 .

[14]  P. Lange,et al.  Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. , 2011, Respiratory medicine.

[15]  W. Grant Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level; implications for meta-analyses and setting vitamin D guidelines , 2011, Dermato-endocrinology.

[16]  Elsebeth Lynge,et al.  The Danish National Patient Register , 2011, Scandinavian journal of public health.

[17]  A. Linneberg,et al.  Indoor exposure to environmental cigarette smoke, but not other inhaled particulates associates with respiratory symptoms and diminished lung function in adults , 2010, Respirology.

[18]  K. Michaëlsson,et al.  Determining Vitamin D Status: A Comparison between Commercially Available Assays , 2010, PloS one.

[19]  R. Hoogenveen,et al.  Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach , 2010, European Respiratory Journal.

[20]  R. Jorde,et al.  Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. , 2010, American journal of epidemiology.

[21]  K. Torén,et al.  Selection bias in a population survey with registry linkage: potential effect on socioeconomic gradient in cardiovascular risk , 2010, European Journal of Epidemiology.

[22]  J. Wielders,et al.  Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock. , 2009, Clinical chemistry.

[23]  C. Camargo,et al.  Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. , 2009, Archives of internal medicine.

[24]  J. Adams,et al.  Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[25]  N. Timpson,et al.  Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization , 2008, Annals of medicine.

[26]  K. Larsson,et al.  COPD diagnosis related to different guidelines and spirometry techniques , 2007, Respiratory research.

[27]  M. Frydenberg,et al.  Does Low Participation in Cohort Studies Induce Bias? , 2006, Epidemiology.

[28]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[29]  R. Scragg,et al.  Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. , 2005, Chest.

[30]  J. Berry,et al.  How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. , 2004, Clinical chemistry.

[31]  Charlotte Glümer,et al.  A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1) , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[32]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[33]  S. Sethi Infectious etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.

[34]  K. Juel,et al.  The Danish registers of causes of death. , 1999, Danish medical bulletin.

[35]  T. F. Andersen,et al.  The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.

[36]  C. Torp‐Pedersen,et al.  Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey , 1998, Journal of hypertension.

[37]  D. Kromhout,et al.  Stability of blood (pro)vitamins during four years of storage at −20 °C: Consequences for epidemiologic research , 1995 .

[38]  D. Kromhout,et al.  Stability of blood (pro)vitamins during four years of storage at -20 degrees C: consequences for epidemiologic research. , 1995, Journal of clinical epidemiology.

[39]  J. Grzybowski,et al.  1,25-Dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. , 1994, Journal of dermatological science.

[40]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[41]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.